HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial.

AbstractBACKGROUND:
Self-expandable metal stents deployed across the gastroesophageal junction predispose to gastroesophageal reflux. The efficacy of a stent with an antireflux mechanism in preventing gastroesophageal reflux was assessed.
METHODS:
Thirty patients with carcinoma of the distal esophagus or of the gastric cardia were randomized to receive either a stent with a windsock-type antireflux valve (FerX-Ella) (n = 15) or a standard open stent (n = 15) of the same design minus the valve. Gastroesophageal reflux was assessed by using standardized questionnaires and by 24-hour pH monitoring 14 days after treatment.
RESULTS:
Technical problems occurred during stent placement in 3 patients: migration (n = 2) and a problem with the introducing system (n = 1). Dysphagia improved from a median score of 3 (liquids only) to 1 (eat some solid food) in the antireflux group and from 3 to 0 (solid foods) in the open stent group ( p > 0.20). Reflux symptoms were reported by 3/12 patients (25%) with an antireflux stent and by 2/14 (14%) with an open stent. In 11 patients, 24-hour pH monitoring was obtained, and increased esophageal acid exposure (normal: <4%) was present with both types of stent: median 24-hour reflux time (9 patients) with the antireflux stent was 23% vs. 10% in (2 patients) with the open stent ( p = NS). Major complications occurred in 3 patients (20%) in each group and included bleeding (n = 3), severe pain (n = 2), and aspiration pneumonia (n = 1). The main cause of recurrent dysphagia was stent migration, which occurred in 7 of the 30 patients (23%).
CONCLUSIONS:
The FerX-Ella antireflux stent provided relief of dysphagia caused by malignancy of the distal esophagus and gastric cardia. However, the antireflux valve failed to prevent gastroesophageal reflux.
AuthorsMarjolein Y V Homs, Peter J Wahab, Ernst J Kuipers, Ewout W Steyerberg, Tim A Grool, Jelle Haringsma, Peter D Siersema
JournalGastrointestinal endoscopy (Gastrointest Endosc) Vol. 60 Issue 5 Pg. 695-702 (Nov 2004) ISSN: 0016-5107 [Print] United States
PMID15557944 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial)
Topics
  • Aged
  • Cardia
  • Deglutition Disorders (etiology, therapy)
  • Esophageal Neoplasms (complications, therapy)
  • Female
  • Gastroesophageal Reflux (prevention & control)
  • Humans
  • Male
  • Prosthesis Failure
  • Recurrence
  • Stents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: